— Know what they know.
Not Investment Advice

300244.SZ SHZ

Dian Diagnostics Group Co.,Ltd.
1W: -3.1% 1M: +11.2% 3M: +1.0% YTD: -17.6% 1Y: +29.9% 3Y: -10.9% 5Y: -35.2%
¥20.52 ($3.06)
+0.33 (+1.63%)
 
SHZ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 67 · ¥12.8B mcap · 525M float · 6.51% daily turnover

Cash Flow Trends

Operating Cash Flow
$1.2B -37.2% ▼
5Y CAGR: +20.1%
Capital Expenditures
$363M +48.2% ▲
5Y CAGR: -2.5%
Free Cash Flow
$844M -30.8% ▼
5Y CAGR: +63.8%
Dividends Paid
$576M -91.5% ▼
Buybacks
$200M -387.2% ▼
Net Change in Cash
-$1.2B +3.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$1.1B$1.5B$1.9B$307M-$169M
Depreciation & Amort.$293M$495M$799M$691M$609M
Stock-Based Comp.$14M$122M$55M$0$0
Change in Working Capital-$607M-$1.3B-$2.6B-$40M-$294M
Other Non-Cash Items$811M$632M$1.5B$1.1B$1.1B
Operating Cash Flow$1.5B$1.3B$1.6B$1.9B$1.2B
— Investing Activities —
Capital Expenditures-$476M-$589M-$948M-$702M-$363M
Acquisitions (Net)-$31M-$41M-$65M-$55M$72M
Investment Purchases-$507M-$389M-$1.0B-$967M-$932M
Investment Sales$174M$459M$958M$1.0B$678M
Other Investing$20M$25M$15M$63M$10M
Investing Cash Flow-$821M-$536M-$1.1B-$626M-$535M
— Financing Activities —
Net Debt Issuance$131M-$97M$1.6B-$2.1B-$497M
Stock Repurchased$0$0-$9M-$41M-$200M
Dividends Paid-$79M-$81M-$84M-$301M-$576M
Other Financing-$126M$53M$141M-$107M-$562M
Financing Cash Flow-$256M-$310M$1.4B-$2.5B-$1.8B
Net Change in Cash$462M$468M$2.0B-$1.2B-$1.2B
Cash End of Period$1.7B$2.1B$4.1B$2.9B$1.8B
Free Cash Flow$1.1B$728M$692M$1.2B$844M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms